Literature DB >> 26187738

The European GWAS-identified risk SNP rs457717 within IQGAP2 is not associated with age-related hearing impairment in Han male Chinese population.

Huajie Luo1, Hao Wu2,3, Hailian Shen4, Haifeng Chen5,6, Tao Yang2,3, Zhiwu Huang2,3, Xiaojie Jin1, Xiuhong Pang2,3, Lei Li2,3, Xianting Hu2, Xuemei Jiang3,7, Zhuping Fan8, Jiping Li9.   

Abstract

This study aimed to test the association between the European GWAS-identified risk IQGAP2 SNP rs457717 (A>G) and age-related hearing impairment (ARHI) in a Han male Chinese (HMC) population. A total of 2420 HMC subjects were divided into two groups [group 70+: >70 years (n = 1306), and group 70-: ≤70 years (n = 1114)]. The participants were categorised into case and control groups according to Z high scores for group 70- and the severity of hearing loss and different audiogram shapes identified by K-means cluster analysis for group 70+. The IQGAP2 tagSNP rs457717 was genotyped in accordance with the different ARHI phenotypes. The genotype distributions of IQGAP2 (AA/AG/GG) were not significantly different between the case and control groups (P = 0.613 for group 70-; P = 0.602 for group 70+). Compared with genotype AA, the ORs of genotypes AG and GG for ARHI were not significantly different following adjustment for other environmental risk factors. We demonstrated that the IQGAP2 TagSNP rs457717 (A/G) was not associated with ARHI in HMC individuals.

Entities:  

Keywords:  Age-related hearing impairment; Association study; Candidate gene; Genotype; IQ motif-containing GTPase activating-like protein; Phenotype

Mesh:

Substances:

Year:  2015        PMID: 26187738     DOI: 10.1007/s00405-015-3711-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  47 in total

Review 1.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

2.  Biologic activity of mitochondrial metabolites on aging and age-related hearing loss.

Authors:  M D Seidman; M J Khan; U Bai; N Shirwany; W S Quirk
Journal:  Am J Otol       Date:  2000-03

3.  The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases.

Authors:  S Brill; S Li; C W Lyman; D M Church; J J Wasmuth; L Weissbach; A Bernards; A J Snijders
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  Genetic and environmental influences on self-reported reduced hearing in the old and oldest old.

Authors:  K Christensen; H Frederiksen; H J Hoffman
Journal:  J Am Geriatr Soc       Date:  2001-11       Impact factor: 5.562

5.  Apolipoprotein E alleles and sensorineural hearing loss.

Authors:  Gwen O'Grady; Abee L Boyles; Marcy Speer; Frank DeRuyter; Warren Strittmatter; Gordon Worley
Journal:  Int J Audiol       Date:  2007-04       Impact factor: 2.117

6.  Distinct PAR/IQGAP expression patterns during murine development: implications for thrombin-associated cytoskeletal reorganization.

Authors:  Lisa D Cupit; Valentina A Schmidt; Frederick Miller; Wadie F Bahou
Journal:  Mamm Genome       Date:  2004-08       Impact factor: 2.957

7.  Changes in hearing thresholds over 10 years in older adults.

Authors:  Terry L Wiley; Rick Chappell; Lakeesha Carmichael; David M Nondahl; Karen J Cruickshanks
Journal:  J Am Acad Audiol       Date:  2008-04       Impact factor: 1.664

8.  Flat threshold and mid-frequency hearing impairment in a Dutch DFNA8/12 family with a novel mutation in TECTA. Some evidence for protection of the inner ear.

Authors:  A R de Heer; R J Pauw; P L M Huygen; R W J Collin; H Kremer; C W R J Cremers
Journal:  Audiol Neurootol       Date:  2008-11-13       Impact factor: 1.854

9.  KCNQ4: a gene for age-related hearing impairment?

Authors:  E Van Eyken; L Van Laer; E Fransen; V Topsakal; N Lemkens; W Laureys; N Nelissen; A Vandevelde; T Wienker; P Van De Heyning; G Van Camp
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

10.  Pharmacological reversal of endothelin-1 mediated constriction of the spiral modiolar artery: a potential new treatment for sudden sensorineural hearing loss.

Authors:  Elias Q Scherer; Wolfgang Arnold; Philine Wangemann
Journal:  BMC Ear Nose Throat Disord       Date:  2005-11-29
View more
  3 in total

Review 1.  Diagnostic and therapeutic applications of genomic medicine in progressive, late-onset, nonsyndromic sensorineural hearing loss.

Authors:  Joaquin E Jimenez; Aida Nourbakhsh; Brett Colbert; Rahul Mittal; Denise Yan; Carlos L Green; Eric Nisenbaum; George Liu; Nicole Bencie; Jason Rudman; Susan H Blanton; Xue Zhong Liu
Journal:  Gene       Date:  2020-04-15       Impact factor: 3.688

2.  Genome-wide association meta-analysis identifies five novel loci for age-related hearing impairment.

Authors:  Andries Paul Nagtegaal; Linda Broer; Nuno R Zilhao; Johanna Jakobsdottir; Charles E Bishop; Marco Brumat; Mark W Christiansen; Massimiliano Cocca; Yan Gao; Nancy L Heard-Costa; Daniel S Evans; Nathan Pankratz; Sheila R Pratt; T Ryan Price; Christopher Spankovich; Mary R Stimson; Karen Valle; Dragana Vuckovic; Helena Wells; Gudny Eiriksdottir; Erik Fransen; Mohammad Arfan Ikram; Chuang-Ming Li; W T Longstreth; Claire Steves; Guy Van Camp; Adolfo Correa; Karen J Cruickshanks; Paolo Gasparini; Giorgia Girotto; Robert C Kaplan; Michael Nalls; John M Schweinfurth; Sudha Seshadri; Nona Sotoodehnia; Gregory J Tranah; André G Uitterlinden; James G Wilson; Vilmundur Gudnason; Howard J Hoffman; Frances M K Williams; André Goedegebure
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

3.  Self-reported hearing loss questions provide a good measure for genetic studies: a polygenic risk score analysis from UK Biobank.

Authors:  Stacey S Cherny; Gregory Livshits; Helena R R Wells; Maxim B Freidin; Ida Malkin; Sally J Dawson; Frances M K Williams
Journal:  Eur J Hum Genet       Date:  2020-03-20       Impact factor: 5.351

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.